189 related articles for article (PubMed ID: 31171308)
1. Peripheral spondyloarthritis: Concept, diagnosis and treatment.
Molto A; Sieper J
Best Pract Res Clin Rheumatol; 2018 Jun; 32(3):357-368. PubMed ID: 31171308
[TBL] [Abstract][Full Text] [Related]
2. Presentation of enthesitis-related arthritis and juvenile-onset spondyloarthritis: a cross-sectional study in a pediatric and adult clinic.
Lanças SHS; Furlan MZB; Fernandes TAP; Drumond SGL; Magalhães CS
Adv Rheumatol; 2024 May; 64(1):39. PubMed ID: 38720369
[TBL] [Abstract][Full Text] [Related]
3. Peripheral spondyloarthritis: a neglected entity-state of the art.
Carron P; De Craemer AS; Van den Bosch F
RMD Open; 2020 May; 6(1):. PubMed ID: 32385142
[TBL] [Abstract][Full Text] [Related]
4. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.
Ramiro S; Nikiphorou E; Sepriano A; Ortolan A; Webers C; Baraliakos X; Landewé RBM; Van den Bosch FE; Boteva B; Bremander A; Carron P; Ciurea A; van Gaalen FA; Géher P; Gensler L; Hermann J; de Hooge M; Husakova M; Kiltz U; López-Medina C; Machado PM; Marzo-Ortega H; Molto A; Navarro-Compán V; Nissen MJ; Pimentel-Santos FM; Poddubnyy D; Proft F; Rudwaleit M; Telkman M; Zhao SS; Ziade N; van der Heijde D
Ann Rheum Dis; 2023 Jan; 82(1):19-34. PubMed ID: 36270658
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis.
Bello N; Etcheto A; Béal C; Dougados M; Moltó A
Arthritis Res Ther; 2016 Feb; 18():42. PubMed ID: 26860612
[TBL] [Abstract][Full Text] [Related]
6. Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis.
Schoels MM; Braun J; Dougados M; Emery P; Fitzgerald O; Kavanaugh A; Kvien TK; Landewé R; Luger T; Mease P; Olivieri I; Reveille J; Ritchlin C; Rudwaleit M; Sieper J; Smolen JS; Wit Md; van der Heijde D
Ann Rheum Dis; 2014 Jan; 73(1):238-42. PubMed ID: 23740234
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of JAK inhibitors on enthesitis in spondyloarthropathy: A scoping literature review.
Jubber A; Tahir H; Moorthy A
Musculoskeletal Care; 2023 Dec; 21(4):1195-1203. PubMed ID: 37501580
[TBL] [Abstract][Full Text] [Related]
8. Cause analysis of conversion to biologics in spondyloarthritis patients with poor response to conventional treatment.
Zhou J; Huang W; Zhang Z; Luo L; Ren F; Huang D; Tang L
Clin Rheumatol; 2023 Dec; 42(12):3251-3255. PubMed ID: 37740841
[TBL] [Abstract][Full Text] [Related]
9. Natural language processing to identify and characterize spondyloarthritis in clinical practice.
Benavent D; Benavent-Núñez M; Marin-Corral J; Arias-Manjón J; Navarro-Compán V; Taberna M; Salcedo I; Peiteado D; Carmona L; de Miguel E;
RMD Open; 2024 May; 10(2):. PubMed ID: 38796183
[TBL] [Abstract][Full Text] [Related]
10. Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain.
Valero-Martínez C; Urgelles JF; Sallés M; Joven-Ibáñez BE; de Juanes A; Ramírez J; Juanola X; Almodóvar R; Laiz A; Moreno M; Pujol M; Beltrán E; Pinto-Tasende JA; Crespí L; Sala-Icardo L; Castañeda S; García-Vicuña R
Front Immunol; 2023; 14():1283251. PubMed ID: 37936691
[TBL] [Abstract][Full Text] [Related]
11. Combination biologics or targeted synthetic disease-modifying anti-rheumatic drugs in the treatment of spondyloarthritis: a systematic literature review.
Abedalweli R; Nguyen M; Deodhar A
Expert Rev Clin Immunol; 2024 Jul; 20(7):735-743. PubMed ID: 38512065
[TBL] [Abstract][Full Text] [Related]
12. Choosing the right treatment for patients with psoriatic arthritis.
Noviani M; Feletar M; Nash P; Leung YY
Ther Adv Musculoskelet Dis; 2020; 12():1759720X20962623. PubMed ID: 33133245
[TBL] [Abstract][Full Text] [Related]
13. Exploring the unifying concept of Spondyloarthritis: a latent class analysis of the REGISPONSER registry.
Michelena X; Sepriano A; Zhao SS; López-Medina C; Collantes-Estévez E; Font-Ugalde P; Juanola X; Marzo-Ortega H
Rheumatology (Oxford); 2024 Jan; ():. PubMed ID: 38237920
[TBL] [Abstract][Full Text] [Related]
14. Screening Tools for Spondyloarthritis in Patients With Psoriasis, Uveitis, and Inflammatory Bowel Disease: A Scoping Review.
Kesarwani V; Sinnappan S; Husni ME; Weisman MH; Ermann J
Arthritis Care Res (Hoboken); 2024 Jun; 76(6):860-870. PubMed ID: 38303576
[TBL] [Abstract][Full Text] [Related]
15. Enthesitis in Spondyloarthritis Including Psoriatic Arthritis-To Inject or Not To Inject?: A Narrative Review.
Tsechelidis OB; Sabido-Sauri R; Aydin SZ
Clin Ther; 2023 Sep; 45(9):852-859. PubMed ID: 37716837
[TBL] [Abstract][Full Text] [Related]
16. Peripheral spondyloarthritis: What have we learned?
Puche-Larrubia MÁ; López-Medina C; Ziadé N
Best Pract Res Clin Rheumatol; 2023 Sep; 37(3):101862. PubMed ID: 37599204
[TBL] [Abstract][Full Text] [Related]
17. The need for comparative data in spondyloarthritis.
Choy E; Baraliakos X; Behrens F; D'Angelo S; de Vlam K; Kirkham BW; Østergaard M; Schett GA; Rissler M; Chaouche-Teyara K; Perella C
Arthritis Res Ther; 2019 Jan; 21(1):32. PubMed ID: 30670074
[TBL] [Abstract][Full Text] [Related]
18. Current Pharmacological Therapies for the Management of Spondyloarthritis: Special Considerations in Older Patients.
Felten R; Toussirot E
Drugs Aging; 2023 Dec; 40(12):1101-1112. PubMed ID: 37902947
[TBL] [Abstract][Full Text] [Related]
19. Correspondence to "Effectiveness and safety of generic tofacitinib in spondyloarthritis: A real-world retrospective analysis from India".
Chen SY; Lin TA; Yeh WB; Chang R
Int J Rheum Dis; 2023 Dec; 26(12):2587-2588. PubMed ID: 37377393
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
